10-K: Horizon Technology Finance Corp Reports Full Year 2024 Results
Annual Results
Horizon Technology Finance Corporation's 10-K filing reveals key financial data and strategic insights for the year ended December 31, 2024, highlighting its investments in technology, life science, healthcare information, services, and sustainability industries.
Summary
- Horizon Technology Finance Corporation is a specialty finance company focusing on lending to and investing in development-stage companies in technology, life science, healthcare information, services, and sustainability industries.
- The company's investment objective is to maximize its portfolio's total return through current income from debt investments and capital appreciation from warrants.
- As of December 31, 2024, the debt investment portfolio consisted of 52 debt investments with an aggregate fair value of $638.8 million.
- Senior Term Loans comprised 86.1% ($550.0 million) of the debt investment portfolio at fair value.
- The company's net assets as of December 31, 2024, were $336.2 million.
- The dollar-weighted annualized yield on average debt investments for the year ended December 31, 2024, was 15.6%.
- The overall total yield for the investment portfolio was 14.5% for the year ended December 31, 2024.
- The company's total return based on market value was (21.3)% for the year ended December 31, 2024.
- The company funded 266 portfolio companies and invested $2.5 billion in debt investments from March 4, 2008 through December 31, 2024.
- The company held warrants to purchase stock in 85 portfolio companies, equity positions in 19 portfolio companies, and success fee arrangements in six portfolio companies as of December 31, 2024.
- The company's investment activities are managed by Horizon Technology Finance Management LLC, its Advisor, under an investment management agreement.
- The company has elected to be regulated as a BDC under the 1940 Act and as a RIC under Subchapter M of the Code.
Sentiment
Score: 5
Explanation: The document presents a mixed sentiment. While it highlights the company's investment strategies and portfolio composition, it also acknowledges the risks and challenges associated with investing in development-stage companies and the competitive market.
Positives
- The company's debt investment portfolio is secured by the tangible and intangible assets of the portfolio companies.
- The company has a disciplined underwriting process and a hands-on approach to portfolio management.
- The company has a well-known brand name and strong relationships with venture capital and private equity firms.
- The company has a long track record of originating, underwriting, and managing Venture Loans.
Negatives
- The company's total return based on market value was (21.3)% for the year ended December 31, 2024.
- The company operates in a highly competitive market for investment opportunities.
- The company is dependent on its Advisor and its key personnel.
- The company's portfolio companies are subject to various risks, including volatility, intense competition, and shortened product life cycles.
Risks
- Political, social and economic uncertainty, including uncertainty related to tariffs, trade disputes, war and inflation, creates and exacerbates risks.
- The company's operation as a BDC imposes numerous constraints and significantly reduces operating flexibility.
- The company will be subject to corporate-level U.S. federal income tax if it is unable to maintain its qualification for tax treatment as a RIC.
- The company is dependent upon management personnel of its Investment Advisor for its future success.
- The company's ability to grow depends on its ability to raise additional capital.
- The company borrows money, which may magnify the potential for gain or loss and may increase the risk of investing in it.
- The company operates in a highly competitive market for investment opportunities.
- The company's Board of Directors may change its investment objective, operating policies and strategies without prior notice or stockholder approval.
- The company's Investment Advisor can resign on 60 days notice, and the company may not be able to find a suitable replacement within that time.
- The company's ability to enter into transactions with its affiliates is restricted.
- The company is exposed to risks associated with changes in interest rates.
- The company is exposed to risks associated with original issue discount and PIK instruments.
- The company's investment strategy focuses on investments in development-stage companies in its Target Industries, which are subject to many risks and would be rated below investment grade.
- The lack of liquidity in the company's investments may adversely affect its business.
- Declines in market prices and liquidity in the corporate debt markets can result in significant net unrealized depreciation of the company's portfolio.
- Investing in the company's common stock involves an above average degree of risk
- Most of the company's portfolio companies will need additional capital, which may not be readily available.
Future Outlook
The company expects its Advisor to continue to employ core strategies including structured investments, enterprise value lending, creative products with attractive risk-adjusted pricing, direct origination, disciplined underwriting, and the use of leverage.
Industry Context
The company operates in a competitive market for investment opportunities in development-stage companies within the technology, life science, healthcare information and services, and sustainability industries.
Comparison to Industry Standards
- The document does not provide specific comparisons to industry standards or comparable companies.
- The document does not provide specific comparisons to industry benchmarks or comparable projects.
- The document does not provide specific comparisons to comparable results.
Related Party Transactions
- The company has entered into an Investment Management Agreement with its Advisor, Horizon Technology Finance Management LLC, under which it pays a base management fee and an incentive fee.
- The company has entered into an Administration Agreement with its Advisor, under which it reimburses the Advisor for its allocable portion of overhead and other expenses.
- The company has entered into a license agreement with Horizon Technology Finance Management LLC, granting it a non-exclusive, royalty-free right to use the service mark Horizon Technology Finance.
Stakeholder Impact
- The company's performance and investment decisions directly impact its shareholders, who receive distributions and are subject to the risks associated with the company's investments.
- The company's lending activities support development-stage companies in technology, life science, healthcare, and sustainability, contributing to innovation and growth in these sectors.
- The company's portfolio companies are affected by its investment decisions and the terms of its debt agreements.
Next Steps
- The company will hold a special meeting of stockholders on February 21, 2025, to approve a new investment advisory agreement with its Advisor.
- The company intends to continue making monthly distributions to its stockholders.
- The company expects to raise additional equity and debt capital opportunistically as needed and, subject to market conditions, to support its future growth.
Key Dates
| Date | Description |
|---|---|
| 2008-03-04 | Compass Horizon Funding Company LLC commenced operations. |
| 2010-03 | Horizon Technology Finance Corporation was organized. |
| 2010-10-29 | Common stock began trading. |
| 2019-08-13 | Completed $160.0 million securitization of secured loans. |
| 2021-03-30 | Issued $57.5 million of 4.875% unsecured notes due 2026. |
| 2022-06-15 | Issued $57.5 million of 6.25% unsecured notes due 2027. |
| 2022-11-09 | Completed $157.8 million securitization of secured loans. |
| 2024-06-20 | Amended Key Facility to extend the date on which the company may request advances under the Key Facility to June 20, 2027 and to extend the maturity date to June 20, 2029. |
| 2024-06-21 | Sold or contributed to HFII certain secured loans made to certain portfolio companies pursuant to the Sale and Servicing Agreement. |
| 2024-10-17 | Issued $20.0 million of 7.125% convertible notes due 2031. |
| 2025-02-21 | Special meeting of stockholders to approve a new investment advisory agreement with the Advisor. |
| 2025-03-04 | There were 40,315,008 shares of the Registrant’s common stock outstanding as of March 4, 2025. |
Keywords
Venture Lending, Debt Investments, Business Development Company, Technology, Life Science, Healthcare, Sustainability, BDC, RIC, Finance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.